Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type V alpha 1 chain is a low-abundance fibrillar collagen found ubiquitously in connective tissues, where it forms heterotrimeric molecules that regulate the assembly and diameter of type I collagen fibers[1][2][4]. It plays a key role in organizing the extracellular matrix and maintaining tissue structural integrity. Mutations in the COL5A1 gene can cause the classical type of Ehlers-Danlos syndrome, characterized by fragile, highly extensible skin and joint hypermobility[2]. Collagen type V alpha 1 chain is also implicated in certain cancers, such as glioblastoma and triple-negative breast cancer, where its overexpression contributes to tumor progression and tissue remodeling[3][7]. The protein binds other extracellular matrix components (such as DNA, heparin, and thrombospondin)[6]. No direct therapeutic drugs are established for this target, and its clinical relevance is primarily in the context of genetic disease and cancer biomarker research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type V alpha 1 chain (COL5A1).